Chlamydophila pneumoniae

Chlamydophila (Chlamydia) pneumoniae is an obligate intracellular pathogen lacking peptidoglycan in its cell wall (thus not visualized well by Gram stain and resistant to beta-lactams). It has a biphasic life cycle: the infectious elementary body (EB) and the metabolically active reticulate body (RB) that replicates within host cell inclusions. Clinically, it causes atypical pneumonia characterized by insidious onset, low-grade fever, nonproductive cough, and often pharyngitis, sinusitis, and hoarseness—collectively giving it a 'walking pneumonia' presentation similar to Mycoplasma pneumoniae. Chest X-ray classically shows patchy, diffuse interstitial infiltrates that appear worse than the patient's clinical presentation (a hallmark of atypical pneumonias). Diagnosis is challenging because the organism is difficult to culture; PCR and serology (IgM/IgG) are the primary diagnostic modalities. Treatment involves macrolides (azithromycin), tetracyclines (doxycycline), or respiratory fluoroquinolones—NOT beta-lactams, since the organism lacks peptidoglycan cell wall targets. Epidemiologically, it spreads via respiratory droplets and is common in crowded settings like military barracks, college dormitories, and schools. There has also been research interest in a possible association between C. pneumoniae infection and atherosclerosis/coronary artery disease, though this link remains controversial and unproven as a causative relationship. It's part of the differential for atypical pneumonia pathogens along with Mycoplasma pneumoniae, Legionella pneumophila, and respiratory viruses.